chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 23.0
Sex: M
Vaccine: COVID19
Symptoms: Tenderness
Clinical narrative: Ear infection; Ear was slightly tender; Scrating caused it to become inflamed; Ear hurts; Ear is now filled with fluids; This is a spontaneous report from a non-contactable consumer, the patient. A 23-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8732), via an unspecified route of administration in the left arm on 24Mar2021 (at the age of 23-year-old), as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had no allergies to medications, food, or other products. Concomitant medications included minoxidil (ROGAINE) and multivitamin (MANUFACTURER UNKNOWN); both taken for unknown indication from an unknown date. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 27Mar2021 at 20:00 the patient experienced ear infection. The patient did not leave the house and had not interacted with anyone. The patient noticed that ear was slightly tender and had agitated by scratching which caused it to become inflamed. The patient reported that ear was filled with fluids and that it hurt. The patient experienced ear infection frequently when patient had cold, and thought the vaccine made his body to react in the same way. On 29Mar2021, the patient was tested for COVID-19 virus test which resulted in negative. The adverse event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of ear infection, tenderness, inflammation, ear pain and fluid in middle ear which included treatment with amoxicillin (MANUFACTURER UNKNOWN). The clinical outcomes of the events ear infection, tenderness, inflammation, ear pain and fluid in middle ear were resolving at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Feeling abnormal, Headache, Lymphadenopathy
Clinical narrative: General yucky feeling; Fever; Chills; Nausea; Swollen lymph nodes; Fatigue; Muscle aches; Headache; This is a spontaneous report from a contactable consumer, the patient. A 30-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 29Mar2021 at 14:00 (at the age of 30-year-old) as a single dose for COVID-19 immunisation. Medical history included diabetes type 1 and irritable bowel syndrome-diarrhea (IBS-D). The patient was allergic to tuberculosis (TB) skin test and curry. Concomitant medications included insulin lispro (HUMALOG) and loratadine (CLARITIN) since an unknown date for unknown indication. The patient previously received unspecified meningitis vaccine (MANUFACTURER UNKNOWN) on an unknown date for unknown indication and experienced allergy to vaccine. The patient also received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6203) via an unspecified route of administration in left arm on 08Mar2021 at 13:15 (at the age of 30-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 30Mar2021 at 01:00, the patient experienced fever, chills, nausea, swollen lymph nodes, fatigue, muscle aches, headache and general yucky feeling. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the events fever, chills, nausea, swollen lymph nodes, fatigue, muscle aches, headache and general yucky feeling were resolving at the time of report.  No follow-up attempts are needed. No further information is expected.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Nausea, Pyrexia
Clinical narrative: General yucky feeling; Fever; Chills; Nausea; Swollen lymph nodes; Fatigue; Muscle aches; Headache; This is a spontaneous report from a contactable consumer, the patient. A 30-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 29Mar2021 at 14:00 (at the age of 30-year-old) as a single dose for COVID-19 immunisation. Medical history included diabetes type 1 and irritable bowel syndrome-diarrhea (IBS-D). The patient was allergic to tuberculosis (TB) skin test and curry. Concomitant medications included insulin lispro (HUMALOG) and loratadine (CLARITIN) since an unknown date for unknown indication. The patient previously received unspecified meningitis vaccine (MANUFACTURER UNKNOWN) on an unknown date for unknown indication and experienced allergy to vaccine. The patient also received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6203) via an unspecified route of administration in left arm on 08Mar2021 at 13:15 (at the age of 30-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 30Mar2021 at 01:00, the patient experienced fever, chills, nausea, swollen lymph nodes, fatigue, muscle aches, headache and general yucky feeling. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the events fever, chills, nausea, swollen lymph nodes, fatigue, muscle aches, headache and general yucky feeling were resolving at the time of report.  No follow-up attempts are needed. No further information is expected.
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain, Vaccination site rash
Clinical narrative: Rash in the right arm around the injection site; Burning sensation in the right arm around the injection site; This is a spontaneous report from a contactable consumer, the patient. A 39-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 29Mar2021 at 14:00 (at the age of 39-years-old) as a single dose for COVID-19 immunisation. Medical history included hypertension and diabetes. The patient had no known allergies. Concomitant medications included lisinopril (MANUFACTURER UNKNOWN), metoprolol tartrate (MANUFACTURER UNKNOWN),  metformin((MANUFACTURER UNKNOWN) and atropine (MANUFACTURER UNKNOWN) taken for unknown indication from an unspecified date. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm right on 08Mar2021 at 14:30 ( at the age of 39-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 31Mar2021 at 13:00,  the patient experienced rash and burning sensation on his right arm around the injection site (vaccination site rash ; vaccination site burning). The events happened 2 days after the shot (as reported). The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care.  The clinical outcome of the events rash in the right arm around the injection site and burning sensation in the right arm around the injection site was not resolved at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Dysgeusia, Fatigue, Headache, Influenza
Clinical narrative: Muscle pain in arm, neck, upper back on side vaccine was administered; Stomach upset; Mild headache; sore throat; fatigue; metal taste in mouth; Feel a bit like the flu but with no fever; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration in the arm left on 30Mar2021 at 16:45 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient was allergic to multiple herbs, spice and some medication (unspecified). Concomitant medications received within 2 weeks of vaccination included hydroxyzine hydrochloride (VISTARIL). Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On 30Mar2021 at 19:00, the patient experienced muscle pain in arm, neck, upper back on the side of vaccine administered, stomach upset, mild headache, sore throat, fatigue, metal taste in mouth and felt a bit like flu but with no fever. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the adverse events. The clinical outcome of muscle pain in arm, neck, upper back on side vaccine was administered, stomach upset, mild headache, sore throat, fatigue, metal taste in mouth and feel a bit like flu was not recovered at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Oropharyngeal pain
Clinical narrative: Muscle pain in arm, neck, upper back on side vaccine was administered; Stomach upset; Mild headache; sore throat; fatigue; metal taste in mouth; Feel a bit like the flu but with no fever; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration in the arm left on 30Mar2021 at 16:45 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient was allergic to multiple herbs, spice and some medication (unspecified). Concomitant medications received within 2 weeks of vaccination included hydroxyzine hydrochloride (VISTARIL). Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On 30Mar2021 at 19:00, the patient experienced muscle pain in arm, neck, upper back on the side of vaccine administered, stomach upset, mild headache, sore throat, fatigue, metal taste in mouth and felt a bit like flu but with no fever. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the adverse events. The clinical outcome of muscle pain in arm, neck, upper back on side vaccine was administered, stomach upset, mild headache, sore throat, fatigue, metal taste in mouth and feel a bit like flu was not recovered at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Feeling abnormal, Headache, Myalgia
Clinical narrative: injection site pain; fatigue; headache; fuzzy headedness; muscle pain; joint pain generally with focus on left knee; This is a spontaneous report from a contactable consumer, the patient. A 70-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6201) via an unspecified route of administration in the arm left on 12Feb2021 at 01:00 (at the age of 70-years-old) and second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6198) via an unspecified route of administration in the arm left on 05Mar2021 (at the age of 70-years-old) as a single dose for COVID-19 immunisation. The patient medical history included seasonal allergies. The patient did not receive any concomitant medications. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient was not tested for COVID-19. On 12Feb2021, the patient experienced injection site pain (vaccination site pain), fatigue, headache, fuzzy headedness, muscle pain and joint pain generally with focus on left knee. The reported adverse events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient received chiropractic treatment at 6 weeks from the first dose. The clinical outcomes of the events injection site pain, fatigue, headache, fuzzy headedness, muscle pain, joint pain generally with focus on left knee were resolving at the time of report.   No follow-up attempts are needed. No further information is expected.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: injection site pain; fatigue; headache; fuzzy headedness; muscle pain; joint pain generally with focus on left knee; This is a spontaneous report from a contactable consumer, the patient. A 70-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6201) via an unspecified route of administration in the arm left on 12Feb2021 at 01:00 (at the age of 70-years-old) and second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6198) via an unspecified route of administration in the arm left on 05Mar2021 (at the age of 70-years-old) as a single dose for COVID-19 immunisation. The patient medical history included seasonal allergies. The patient did not receive any concomitant medications. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient was not tested for COVID-19. On 12Feb2021, the patient experienced injection site pain (vaccination site pain), fatigue, headache, fuzzy headedness, muscle pain and joint pain generally with focus on left knee. The reported adverse events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient received chiropractic treatment at 6 weeks from the first dose. The clinical outcomes of the events injection site pain, fatigue, headache, fuzzy headedness, muscle pain, joint pain generally with focus on left knee were resolving at the time of report.   No follow-up attempts are needed. No further information is expected.
Sex: U
Vaccine: COVID19
Symptoms: Heart rate increased
Clinical narrative: severe fast/rapid/speeding heartbeat; This is a spontaneous report from a contactable consumer. This consumer reported for another patient that: A patient of unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as single dose for covid-19 immunization. The patient medical history and concomitant medications were not reported. On an unspecified date patient experienced severe fast/rapid/speeding heartbeat. Reporter stated that the technician doing the EKG said that she was the fourth person with speeding/rapid heart rate from the Pfizer vaccine. The outcome of the event was reported as unknown.   Information about Lot/batch number has been requested.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021358507 same reporter/drug/AE, different patient
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Insomnia
Clinical narrative: Insomnia; This is a spontaneous report from a contactable consumer, the patient. A 29-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737), via an unspecified route of administration in the left arm on 31Mar2021 at 14:45 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma. Concomitant medication was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 31Mar2021 at 21:00, the patient experienced insomnia. The patient did not receive any treatment for the event. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the insomnia was recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 43.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Headache
Clinical narrative: Headache; Joint aches; This is a spontaneous report from a contactable consumer, the patient. A 43-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the arm left on 31Mar2021 at 10:45 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history and concomitant medications. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3247) via an unspecified route of administration in the arm left on 10Mar2021 at 11:30 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. On 01Apr2021 at 06:00 the patient experienced headache and joint aches. The adverse events did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. The patient did not received any treatment for the adverse events. The clinical outcome of the adverse events headache and joint aches were resolving.   No follow-up attempts are needed. No further information is expected.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Fatigue, Headache, Hyperhidrosis
Clinical narrative: Next day past noon, continue fatigue with sweating and chills, followed by fever highest of 102.3 that started at 8pm; Second day, fever continues with muscle/body pain.; Second day, fever continues with muscle/body pain.; Next day past noon, continue fatigue with sweating and chills, followed by fever highest of 102.3 that started at 8pm; Next day past noon, continue fatigue with sweating and chills, followed by fever highest of 102.3 that started at 8pm; pain at site of injection; slight headache at top portion of head; extreme fatigue; This is a spontaneous report from a contactable consumer, the patient. A 29-years-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EP7534) via unspecified route of administration in the left arm on 31Mar2021 at 10:30 (at the age of 29-years-old), as a single dose for COVID-19 immunisation. The patient medical history included fibromyalgia and rheumatoid arthritis. The patient had received concomitant medications within two weeks included duloxetine hydrochloride (CYMBALTA) 60 miligrams and meloxicam (MOBIC), from unknown dates for unknown indications. The patient had not received any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 31Mar2021 at 14:00, the patient initially had pain at site of injection, slight headache at top portion of head, extreme fatigue. On 01Apr2021 (next day past noon), continued fatigue with sweating and chills, followed by fever highest of 102.3 (unspecified unit) that started at 20:00. On 01Apr2021, second day, fever continued with muscle and body pain. The patient did not receive any treatment for the reported events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events vaccination site pain, headache, fatigue, sweating, fever, muscle pain and body pain were resolving at the time of this report  No follow-up attempts are needed. No further information is expected.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Pain, Pyrexia, Vaccination site pain
Clinical narrative: Next day past noon, continue fatigue with sweating and chills, followed by fever highest of 102.3 that started at 8pm; Second day, fever continues with muscle/body pain.; Second day, fever continues with muscle/body pain.; Next day past noon, continue fatigue with sweating and chills, followed by fever highest of 102.3 that started at 8pm; Next day past noon, continue fatigue with sweating and chills, followed by fever highest of 102.3 that started at 8pm; pain at site of injection; slight headache at top portion of head; extreme fatigue; This is a spontaneous report from a contactable consumer, the patient. A 29-years-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EP7534) via unspecified route of administration in the left arm on 31Mar2021 at 10:30 (at the age of 29-years-old), as a single dose for COVID-19 immunisation. The patient medical history included fibromyalgia and rheumatoid arthritis. The patient had received concomitant medications within two weeks included duloxetine hydrochloride (CYMBALTA) 60 miligrams and meloxicam (MOBIC), from unknown dates for unknown indications. The patient had not received any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 31Mar2021 at 14:00, the patient initially had pain at site of injection, slight headache at top portion of head, extreme fatigue. On 01Apr2021 (next day past noon), continued fatigue with sweating and chills, followed by fever highest of 102.3 (unspecified unit) that started at 20:00. On 01Apr2021, second day, fever continued with muscle and body pain. The patient did not receive any treatment for the reported events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events vaccination site pain, headache, fatigue, sweating, fever, muscle pain and body pain were resolving at the time of this report  No follow-up attempts are needed. No further information is expected.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Inappropriate schedule of product administration, Lymph node pain, Lymphadenopathy, Vaccination site rash
Clinical narrative: Rash around injection site on left arm.; swollen  lymph nodes under left arm; painful lymph nodes under left arm; Headache; Inappropriate schedule of vaccine administered.; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration in the left arm on 30Mar2021 at 12:00 (at the age of 51-years-old) as a single dose for COVID-19 immunisation. Medical history was reported as none. The patient had allergies to sulfa drugs (unspecified) and codeine (MANUFACTURER UNKNOWN). Concomitant medications included fexofenadine hydrochloride (ALLEGRA), mometasone furoate (NASONEX) and vitamin B complex (MANUFACTURER UNKNOWN). The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration in the right arm on 15Mar2021 (at the age of 51-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient was not tested for COVID-19. On 31Mar2021 at 18:00, 30 hours after vaccination, the patient experienced rash around injection site on left arm, extremely swollen and painful lymph nodes under left arm and headache. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measure was taken as a result of events. The clinical outcome of the events rash around injection site on left arm, extremely swollen and painful lymph nodes under left arm and headache was not recovered and the outcome of inappropriate schedule of vaccine administration was unknown at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Fatigue, Headache, Pain
Clinical narrative: Body aches; Chills; 102.3 fever; Fatigue; Headache; This is a spontaneous report from a contactable consumer, the patient. A 35-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via an unspecified route of administration on 30Mar2021 at 12:15 (at the age of 35-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6205) via an unspecified route of administration on 09Mar2021 at 11:30 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 31Mar2021, the patient experienced body aches, chills, 102.3 fever, fatigue and headache. The adverse events did not result in a visit to the doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events body aches, chills, 102.3 fever, fatigue and headache. The clinical outcomes of the events body aches, chills, 102.3 fever, fatigue and headache were resolved on an unknown date in 2021.   No follow-up attempts are needed. No further information is expected.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Body aches; Chills; 102.3 fever; Fatigue; Headache; This is a spontaneous report from a contactable consumer, the patient. A 35-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via an unspecified route of administration on 30Mar2021 at 12:15 (at the age of 35-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6205) via an unspecified route of administration on 09Mar2021 at 11:30 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 31Mar2021, the patient experienced body aches, chills, 102.3 fever, fatigue and headache. The adverse events did not result in a visit to the doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events body aches, chills, 102.3 fever, fatigue and headache. The clinical outcomes of the events body aches, chills, 102.3 fever, fatigue and headache were resolved on an unknown date in 2021.   No follow-up attempts are needed. No further information is expected.
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Headache, Nausea, Vaccination site pain, Vaccination site swelling
Clinical narrative: Headache; site soreness; site swelling; nausea; tiredness; This is a spontaneous report from a contactable consumer, the patient. A 49-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: eR8727) via an unspecified route of administration in the arm right on 30Mar2021 at 14:00 (at the age of 49-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 31Mar2021, the patient experienced headache, site soreness, site swelling, nausea and tiredness. The patient did not receive any treatment for the events. The clinical outcome of the events headache, vaccination site pain, vaccination site swelling, nausea and fatigue was recovering at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Malaise, Musculoskeletal stiffness, Myalgia, Vaccination site pain
Clinical narrative: Moderate to severe injection site pain; Injection site stiffness; muscle aches; chills; a general unwell feeling; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old non pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8734), via an unspecified route of administration in the left arm on 31Mar2021 at 11:15, (at the age of 42-years old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. The patient did not take any concomitant medication. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination the patient was not tested for COVID-19. On 01Apr2021, at 00:00, the patient experienced moderate to severe injection site pain and stiffness, muscle aches, chills, and a general unwell feeling. The patient woke up at 6:30, on 01Apr2021 feeling stiff and sore, but much better. The patient did not receive any treatment for the adverse events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event severe injection site pain, chills, a general unwell feeling, stiffness and muscle aches was recovered on 01Apr2021.   No follow-up attempts are needed. No further information is expected.
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Headache, Malaise, Pain
Clinical narrative: Same symptoms as covid !! Cold chills; aching, pain; sick feeling; headache; This is a spontaneous report received from a contactable consumer, the patient. A 56-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Er8727), via an unspecified route of administration in the left arm on 30Mar2021 at 19:00 (at the age of 56-years-old), as a single dose for COVID-19 immunisation. Medical history included prostate cancer, penicillin allergy and COVID-19 (which was diagnosed prior to the vaccination). Concomitant medication was not reported. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Since the vaccination, the patient had not been tested for COVID-19. On 30Mar2021 at 20:00 (one day after vaccination), the patient experienced the same symptoms as COVID which includes cold chills, pain, sick feeling and headache. The patient did not receive any treatment for the reported events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events chills, pain, feeling sick and headache was resolving at the time of the report.   No follow-up attempts are possible. No further information is expected.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Burning sensation, Chills, Fatigue, Hot flush, Lacrimation increased
Clinical narrative: chills; fever; fatigue; face hot to touch; blotchy skin.; Eyes watering; burning of face.; This is a spontaneous report from a contactable consumer, the patient. A 45-year-old non-pregnant female patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on an unspecified date in Mar2021 at 13:00 (at the age of 45-years-old) as a single dose for COVID-19 immunisation. Medical history included pre-diabetic and hypothyroidism. The patient had no known allergies. Concomitant medications included metformin (MANUFACTURER UNKNOWN), semaglutide (OZEMPIC) and levothyroxine sodium (SYNTHROID). Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to COVID vaccine. On an unknown date in Mar2021 at 21:30, the patient experienced chills, fever, and fatigue for the first 2 days, hot to touch and blotchy skin on the fourth day. The patient experienced eyes watering from the burning of face. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatments for the events. The clinical outcomes of the events chills, fever, fatigue, face hot to touch, watering eyes, skin blotches and burning of face were recovering.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Rash macular
Clinical narrative: chills; fever; fatigue; face hot to touch; blotchy skin.; Eyes watering; burning of face.; This is a spontaneous report from a contactable consumer, the patient. A 45-year-old non-pregnant female patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on an unspecified date in Mar2021 at 13:00 (at the age of 45-years-old) as a single dose for COVID-19 immunisation. Medical history included pre-diabetic and hypothyroidism. The patient had no known allergies. Concomitant medications included metformin (MANUFACTURER UNKNOWN), semaglutide (OZEMPIC) and levothyroxine sodium (SYNTHROID). Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to COVID vaccine. On an unknown date in Mar2021 at 21:30, the patient experienced chills, fever, and fatigue for the first 2 days, hot to touch and blotchy skin on the fourth day. The patient experienced eyes watering from the burning of face. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatments for the events. The clinical outcomes of the events chills, fever, fatigue, face hot to touch, watering eyes, skin blotches and burning of face were recovering.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Inflammation, Pruritus, Vaccination site pain
Clinical narrative: This is a spontaneous report from a contactable consumer, the patient. A 54-year-old non-pregnant female patient received her second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the arm left on 31Mar2021 at 08:00 (at the age of 54-year-old) as a single dose for COVID-19 immunisation. Medical history included asthmatic, blood pressure high and type 2 diabetes mellitus. The patient's concomitant medications included unspecified medications for asthmatic, high blood pressure and type 2 diabetes mellitus. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN) via an unspecified route of administration in the right arm on 10Mar2021 at 09:00 as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient was not tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 31Mar2021, on the day of vaccination, the patient experienced a very sore injection site area, itchy face-cheek and felt a little inflamed and fatigue. The patient did not receive any treatment for the reported events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events very sore injection site area, itchy face-cheek area, fatigue and inflammation was recovering at the time of the report.   No follow-up attempts are needed. No further information is expected.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Bone pain, Lymphadenopathy
Clinical narrative: swollen lymph node on collarbone area; collarbone on the right side started hurting; This is a spontaneous report received from a contactable consumer, the patient. A 42-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EP7534) via an unspecified route of administration in the right arm on 27Mar2021 at 11:00 (at the age of 42-years-old), as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications included levocetirizine dihydrochloride (XYZAL) and ethinylestradiol, norgestimate (TRI-SPRINTEC) all from an unknown date for unknown indication. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6199) via an unspecified route of administration in the right arm on 06Mar2021 (at the age of 42-years-old), as a single dose for COVID-19 immunisation. The patient did not have a history of allergies to medications, food or other products. The patient had not received other vaccines within 4 weeks prior to the COVID-19 vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 27Mar2021 at 23:00, the patient experienced collarbone hurting on the right side and after 2 days on 29Mar2021, the patient had a swollen lymph node on collarbone area, it was currently still swollen. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive treatment for the reported events. The clinical outcomes for the events collarbone hurting and swollen lymph nodes on collarbone area was not recovered at the time of report.   No follow-up attempts are needed. No further information is expected.
Age: 18.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature fluctuation, Insomnia
Clinical narrative: Couldnt sleep; fluctuating body temperature.; This is a spontaneous report from a contactable consumer, the patient. A 18-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the arm left on 31Mar2021 at 10:30 (at the age of 18-year-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient did not take any concomitant medication. The patient did not have allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Post vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 31Mar2021 at 12:00 the patient was not able to sleep and experienced fluctuating body temperature. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The patient did not receive any treatment for the reported adverse events. The clinical outcome of the event difficulty sleeping and fluctuating body temperature was resolving at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Disturbance in attention, Fatigue, Pain
Clinical narrative: Fatigue; chills; body ache; brain fog; This is a spontaneous report from a contactable consumer, the patient. A 54-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration in the right arm on 31Mar2021 at 08:15 (at the age of 54-years-old) as a single dose for COVID-19 vaccination. Medical history included chronic hives. The patient did not receive any medication within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 31Mar2021 at 09:00 the patient experienced brain fog, fatigue, chills, body ache. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the adverse events. The clinical outcome of the events  brain fog, fatigue, chills, body ache was recovering at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Hypersomnia, Pyrexia
Clinical narrative: chills; low grade fever; extremely exhausted; slept most of the day; This is a spontaneous report from a contactable consumer, the patient. A 24-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6203) via an unspecified route of administration in the left arm on 24Mar2021 at 09:15 (at the age of 24-years-old) as a single dose for COVID-19 immunisation. Medical history included inflamed kidney (right side). Concomitant medications included ethinylestradiol (+) norgestimate (ORTHO TRI-CYCLEN LO), vitamin D NOS (MANUFACTURER UNKNOWN) and sertraline (MANUFACTURER UNKNOWN) for an unknown indication and from an unknown date. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6203) via an unspecified route of administration in the right arm on 03Mar2021 at 09:15 (at the age of 24-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to COVID vaccine. On 25Mar2021, the patient woke up at 02:00 with chills which then felt like it turned into a low-grade fever. The chills went away in the early morning, but then the patient was extremely exhausted and slept most of the day. The patient reported that she felt better the following day. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported events. The clinical outcomes of the events chills, low grade fever, extremely exhausted and slept most of the day were recovered on an unknown date in Mar2021.   No follow-up attempts are needed. No further information is expected.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Eye pain
Clinical narrative: Right eye pain when blinking.; This is a spontaneous report from a contactable consumer, the patient. A 67-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: FR8734) via an unspecified route of administration in the right arm on 29Mar2021 at 11:45 (at the age of 67-year-old) as a single dose for COVID-19 immunisation. Medical history included high blood pressure and high cholesterol. The patient did not have any allergies to medications, food, or other products. Concomitant medications included atorvastatin (MANUFACTURER UNKNOWN) and hydrochlorothiazide, lisinopril (LISINOPRIL HCT). Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. One day after vaccination, on 30Mar2021, the patient experienced mild but definitely noticeable right eye pain when blinking and that was lasted for about 8 hours. It was felt like a hard contact lenses were in upper part of eye. After a few hours, it occurred to the patient to check the internet to see if that was related to the vaccine, and then she found many similar reports. The patient did not receive any treatment for the event. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event right eye pain when blinking was resolved on 30Mar2021.  No follow-up attempts are needed. No further information is expected.